4 ms·
Worse, other commercial researches will be wasting their time with busywork to find a non-patented analog which they can claim for themselves, instead of workin
by taneq 10y ago
Worse, other commercial researches will be wasting their time with busywork to find a non-patented analog which they can claim for themselves, instead of working on new things.
- nanofortnight 10y agoThat's not actually a bad thing. The first signs of resistance occur on average 1~2 years after introduction of a novel abx; the search for variants helps to extend the usable life of a new family of antibiotics.
- refurb 10y agoWhy is finding a non-patented analog a bad thing? A lot of our medical discoveries are incremental advancements brought about work on analogs. Maybe a company will find a new mechanism of action when they look at analogs? Maybe a less toxic version? Maybe the lead compound fails but the backups work?